Secukinumab, sold under the brand name Cosentyx, is a human IgG1κ monoclonal antibody used for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. Reference standards of Secukinumab API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Secukinumab - API Standards [catalogue_number] => PA 19 2010000 [category_ids] => ,78,70,82,76, [chemical_name] => [weight] => NA [form] => NA [cas] => 1229022-83-6 [pslug] => 1229022-83-6-secukinumab-api-pa192010000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 19 2010000
CAS :
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....